Trial results of idelalisib with bendamustine and rituximab in CLL
New CLL treatments, the standard of care and the importance of clonal evolution
Information is key: why patients need to be empowered to learn about their disease
Can ibrutinib be used as a first-line treatment in CLL?
Current research into drug treatments for CLL - specifically ibrutinib, idelalisib and venetoclax